Phase I clinical trials of aroA aroD and aroA aroD htrA attenuated S. typhi vaccines; effect of formulation on safety and immunogenicity

Author: Dilts D.A.   Riesenfeld-Orn I.   Fulginiti J.P.   Ekwall E.   Granert C.   Nonenmacher J.   Brey R.N.   Cryz S.J.   Karlsson K.   Bergman K.   Thompson T.   Hu B.   Bruckner A.H.   Lindberg A.A.  

Publisher: Elsevier

ISSN: 0264-410X

Source: Vaccine, Vol.18, Iss.15, 2000-02, pp. : 1473-1484

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content